David Risinger
Stock Analyst at Leerink Partners
(4.98)
# 57
Out of 4,581 analysts
1081
Total ratings
65.5%
Success rate
32.9%
Average return
Main Sectors:
Stocks Rated by David Risinger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintained: Buy | n/a | $1,210.02 | - | 120 | Jul 17, 2026 | |
| JNJ Johnson & Johnson | Maintained: Buy | $265 → $276 | $265.53 | +3.94% | 54 | Jul 17, 2026 | |
| ORKA Oruka Therapeutics | Reiterated: Buy | n/a | $88.07 | - | 15 | Jun 2, 2026 | |
| ANAB AnaptysBio | Reiterated: Buy | n/a | $52.14 | - | 33 | May 27, 2026 | |
| REGN Regeneron Pharmaceuticals | Downgraded: Hold | $641 | $695.42 | -7.83% | 58 | May 18, 2026 | |
| IMA ImageneBio | Maintained: Buy | $30 → $24 | $5.70 | +321.05% | 2 | May 8, 2026 | |
| TRAX First Tracks Biotherapeutics | Initiated Coverage: Buy | $46 | $41.87 | +9.86% | 1 | Apr 24, 2026 | |
| AMGN Amgen | Maintained: Hold | n/a | $387.64 | - | 42 | Jan 13, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Buy | $60 | $63.10 | -4.91% | 71 | Jan 13, 2026 | |
| ABBV AbbVie | Maintained: Buy | n/a | $263.30 | - | 72 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $83.28 | - | 37 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $525 | $483.33 | +8.62% | 44 | Dec 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $79.92 | - | 58 | Dec 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $32 | $32.87 | -2.65% | 47 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $26 | $25.15 | +3.38% | 90 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $52.98 | - | 27 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $14.82 | - | 9 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $44.85 | - | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $28.43 | - | 13 | Sep 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.30 | - | 5 | Aug 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 | $16.85 | -22.85% | 21 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $44 | $47.35 | -7.07% | 24 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $27 → $23 | $54.49 | n/a | 2 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $38.10 | n/a | 1 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.56 | n/a | 1 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $41.85 | n/a | 1 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $91 | $132.73 | n/a | 12 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $10.68 | n/a | 1 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $33 | $13.54 | n/a | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $176 | $255.97 | n/a | 12 | May 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $20 → $22 | $36.95 | n/a | 15 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 | $130.36 | n/a | 34 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $16 | $17.82 | n/a | 24 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53 → $45 | $10.43 | n/a | 19 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $49.35 | $6.56 | n/a | 32 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $22 | $48.34 | n/a | 19 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $8 → $9 | $34.71 | n/a | 29 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $167 → $41 | $26.39 | n/a | 8 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $167 → $174 | $77.93 | n/a | 16 | Nov 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $51 | $59.18 | n/a | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $3 | $19.10 | n/a | 4 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $318.61 | n/a | 2 | Nov 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $117.74 | n/a | 3 | Sep 21, 2012 |
Eli Lilly and Company
Jul 17, 2026
Maintained: Buy
Price Target: n/a
Current: $1,210.02
Upside: -
Johnson & Johnson
Jul 17, 2026
Maintained: Buy
Price Target: $265 → $276
Current: $265.53
Upside: +3.94%
Oruka Therapeutics
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $88.07
Upside: -
AnaptysBio
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $52.14
Upside: -
Regeneron Pharmaceuticals
May 18, 2026
Downgraded: Hold
Price Target: $641
Current: $695.42
Upside: -7.83%
ImageneBio
May 8, 2026
Maintained: Buy
Price Target: $30 → $24
Current: $5.70
Upside: +321.05%
First Tracks Biotherapeutics
Apr 24, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $41.87
Upside: +9.86%
Amgen
Jan 13, 2026
Maintained: Hold
Price Target: n/a
Current: $387.64
Upside: -
Bristol-Myers Squibb Company
Jan 13, 2026
Maintained: Buy
Price Target: $60
Current: $63.10
Upside: -4.91%
AbbVie
Jan 13, 2026
Maintained: Buy
Price Target: n/a
Current: $263.30
Upside: -
Jan 8, 2026
Maintained: Hold
Price Target: n/a
Current: $83.28
Upside: -
Dec 29, 2025
Maintained: Buy
Price Target: $525
Current: $483.33
Upside: +8.62%
Dec 24, 2025
Maintained: Buy
Price Target: n/a
Current: $79.92
Upside: -
Dec 15, 2025
Reiterated: Buy
Price Target: $22 → $32
Current: $32.87
Upside: -2.65%
Dec 9, 2025
Maintained: Hold
Price Target: $26
Current: $25.15
Upside: +3.38%
Oct 1, 2025
Reiterated: Buy
Price Target: n/a
Current: $52.98
Upside: -
Sep 17, 2025
Maintained: Buy
Price Target: n/a
Current: $14.82
Upside: -
Sep 4, 2025
Reiterated: Buy
Price Target: n/a
Current: $44.85
Upside: -
Sep 1, 2025
Maintained: Buy
Price Target: n/a
Current: $28.43
Upside: -
Aug 17, 2025
Reiterated: Buy
Price Target: n/a
Current: $6.30
Upside: -
Aug 13, 2025
Maintained: Hold
Price Target: $13
Current: $16.85
Upside: -22.85%
Aug 7, 2025
Maintained: Buy
Price Target: $60 → $44
Current: $47.35
Upside: -7.07%
Apr 16, 2025
Maintained: Sell
Price Target: $27 → $23
Current: $54.49
Upside: n/a
Feb 24, 2025
Initiated Coverage: Buy
Price Target: $28
Current: $38.10
Upside: n/a
Jan 17, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.56
Upside: n/a
May 1, 2024
Reiterated: Buy
Price Target: n/a
Current: $41.85
Upside: n/a
Apr 28, 2023
Maintained: Hold
Price Target: $91
Current: $132.73
Upside: n/a
Mar 14, 2023
Maintained: Buy
Price Target: n/a
Current: $10.68
Upside: n/a
Jun 11, 2021
Initiated Coverage: Hold
Price Target: $33
Current: $13.54
Upside: n/a
May 21, 2021
Reiterated: Hold
Price Target: $176
Current: $255.97
Upside: n/a
May 13, 2021
Maintained: Sell
Price Target: $20 → $22
Current: $36.95
Upside: n/a
Apr 1, 2021
Maintained: Buy
Price Target: $90
Current: $130.36
Upside: n/a
Mar 10, 2021
Maintained: Hold
Price Target: $18 → $16
Current: $17.82
Upside: n/a
Mar 5, 2021
Maintained: Hold
Price Target: $53 → $45
Current: $10.43
Upside: n/a
Feb 26, 2021
Maintained: Hold
Price Target: $49.35
Current: $6.56
Upside: n/a
Dec 21, 2020
Maintained: Hold
Price Target: $16 → $22
Current: $48.34
Upside: n/a
Dec 21, 2020
Maintained: Sell
Price Target: $8 → $9
Current: $34.71
Upside: n/a
Nov 23, 2020
Maintained: Buy
Price Target: $167 → $41
Current: $26.39
Upside: n/a
Nov 13, 2020
Maintained: Hold
Price Target: $167 → $174
Current: $77.93
Upside: n/a
Jul 13, 2020
Initiated Coverage: Hold
Price Target: $51
Current: $59.18
Upside: n/a
Apr 2, 2020
Maintained: Hold
Price Target: $18 → $3
Current: $19.10
Upside: n/a
Nov 16, 2015
Upgraded: Hold
Price Target: n/a
Current: $318.61
Upside: n/a
Sep 21, 2012
Maintained: Buy
Price Target: $36
Current: $117.74
Upside: n/a